Abstract:Ferroptosis is a novel form of non-apoptotic regulated cell death (RCD), with distinct characteristics and functions in physical conditions and multiple diseases such as cancers. Unlike apoptosis and autophagy, this new RCD is an iron-dependent cell death with features of lethal accumulation of reactive oxygen species (ROS) and over production of lipid peroxidation. Excessive iron from aberrant iron metabolisms or the maladjustment of the two main redox systems thiols and lipid peroxidation role as the major causes of ROS generation, and the redox-acrive ferrous (intracellular labile iron) is a crucial factor for the lipid peroxidation. Regulation of ferrroptosis also involves different pathways such as mevalonate pathway, P53 pathway and p62-Keap1-Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway. Ferroptosis roles as a double-edged sword either suppressing or promoting tumor progression with the release of multiple signaling molecules in the tumor microenvironment. Emerging evidence suggests ferroptosis as a potential target for cancer therapy and ferroptosis inducers including small molecules and nanomaterials have been developed. The application of ferroptosis inducers also relates to overcoming drug resistance and preventing tumor metastasis, and may become a promising strategy combined with other anti-cancer therapies. Here, we summarize the ferroptosis characters from its underlying basis and role in cancer, followed by its possible applications in cancer therapies and challenges maintained.

Protocol of CRISPR-Cas9 Knockout Screens for Identifying Ferroptosis Regulators

Targeting Ferroptosis in Breast Cancer

The role of non-coding RNAs in ferroptosis regulation

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

CRISPR screening identifies PRMT1 as a key pro-ferroptotic gene via a two-layer regulatory mechanism

Understanding the unique mechanism of ferroptosis: a promising therapeutic target

A guideline on the molecular ecosystem regulating ferroptosis

Context-dependent regulation of ferroptosis sensitivity

FERREG: ferroptosis-based regulation of disease occurrence, progression and therapeutic response

ChIP and ChIRP Assays in Ferroptosis.

Protocol for detection of ferroptosis in cultured cells

The Chemistry and Biology of Ferroptosis

PAR-CLIP Assay in Ferroptosis.

Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones

Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis

Identification of essential sites of lipid peroxidation in ferroptosis

Ferroptosis in life: To be or not to be

The application of approaches in detecting ferroptosis

CRISPR activation screens identify the SWI/SNF ATPases as suppressors of ferroptosis

Ferroptosis Regulation by Nutrient Signalling

Deciphering Ferroptosis: From Molecular Pathways to Machine Learning-Guided Therapeutic Innovation